Rimegepant (Vydura)

Decision Date:
August 2023



  • NICE TA906 - Rimegepant for preventing migraine. ICB commissioned
  • NICE TA919 - Rimegepant for treating migraine. ICB commissioned (decision date November 2023)


Red Drug Classifications

  • 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
  • 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
  • 3: Requiring long term on-going monitoring of toxicity by a specialist (either because of difficulty in recognising side effects or high cost of investigations to identify toxicity)

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app